drugset / Trial / NCT00405964

Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)

NCT00405964

Phase 3 Completed 716 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis who meet the criteria for persistent allergic rhinitis (PER)

Timeline

Start
2006-09
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Desloratadine Small molecule 5 mg

Indications